Medical Planning and Response to a Nuclear Detonation Working Group
|
Other
|
CDC, FDA, OS
|
NCI
|
2012
|
|
Meta-Analysis of the Risk of Guillain-Barre Syndrome Following H1N1 Vaccination
|
Advisory Group
|
FDA
|
NIAID
|
2011
|
|
Microphysiological Systems for Drug Efficacy and Toxicity Testing
|
Research Initiative
|
FDA
|
NCATS, NCI, NEI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NINDS, NINR, OD/ DPCPSI, OD/ DPCPSI/ ORWH
|
2012
|
|
Million Hearts
|
Advisory Group
|
ACL, AHRQ, CDC, CMS, FDA, HRSA, SAMHSA
|
NHLBI, NINDS
|
2010
|
|
Mobile apps for data collection on adverse events of medication or device during public health emergencies
|
Resource Development
|
FDA
|
NLM
|
2012
|
|
Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group
|
Research Initiative
|
CMS, FDA
|
NHLBI, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIEHS, OD/ DPCPSI
|
2000
|
|
Muscular Dystrophy Coordinating Committee (MDCC)
|
Advisory Group
|
ACF, CDC, FDA, HRSA
|
NHLBI, NIAMS, NICHD, NINDS
|
2002
|
|